New research has found that with a budget of just $1 million, an annual fecal immunochemical test screening program could potentially screen eight times as many people and prevent twice as many CRC cases as a colonoscopy screening program, according to a Center for Advancing Health report.
Though colonoscopy detects more polyps and adenomas than FIT, the question of budget becomes an issue. With a contained budget, an FIT screening program allows more low-income and uninsured patients to be screened, thus expanding the scope of the program and potential to save lives.
More articles on gastroenterology:
New products drive Boston Scientifics’ Q3 sales
PENTAX Medical launches new HD endoscopes: 4 things to know
5 gastroenterologists making the news
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.